Yunhan Tao, Huimin Yu, Yunxi Ma, Mingzhu Yuan, Guochong Chen, Jun Liu, Xi Chen, Xufang Sun
{"title":"Multimodal Exploratory Analysis of Persistent Diabetic Macular Edema: Integrating Aqueous Humour Metabolomics, Clinical and OCT Features.","authors":"Yunhan Tao, Huimin Yu, Yunxi Ma, Mingzhu Yuan, Guochong Chen, Jun Liu, Xi Chen, Xufang Sun","doi":"10.1111/dom.71173","DOIUrl":"10.1111/dom.71173","url":null,"abstract":"<p><strong>Purpose: </strong>This exploratory study integrates aqueous humour metabolomic data with clinical and imaging features to examine candidate biomarkers and characterize multimodal patterns associated with persistent diabetic macular edema (pDME).</p><p><strong>Methods: </strong>In this prospective cohort study, DME patients were treated with monthly anti-VEGF injections over 3 months and categorized as pDME and non-pDME groups based on central subfield thickness and best-corrected visual acuity. We then carried out a nested case-control comparison of these groups, performing untargeted metabolomic analysis on aqueous humour samples. Comparison of clinical data, OCT parameters, and metabolites was performed. Logistic regression models were constructed to explore associations between multimodal features and pDME in the metabolomics subset.</p><p><strong>Results: </strong>A total of 103 patients (146 eyes) were finally included in the analysis. The pDME patients had significantly higher BMI (25.20 vs. 23.27, p = 0.004) and triglyceride (1.80 vs. 1.50, p = 0.003) levels when compared with non-pDME patients. A higher rate of disorganization of retinal inner layers (DRIL, p = 0.026) and vitreoretinal interface abnormality (p = 0.009), but a lower rate of SRF (p = 0.019), was found in the pDME group. Metabolomics analysis revealed 405 differentially expressed metabolites, and purine metabolism (p = 0.001, Q = 0.024) and DNA repair pathway (p < 0.001, Q = 0.013) were significantly enriched. Purine score and DNA repair score were both significantly higher in the pDME group compared with the non-pDME group (p < 0.001). ROC analysis demonstrated metabolomic markers, particularly the purine score, showed stronger group-wise separation for pDME than clinical and OCT features (LOOCV AUC 0.963 vs. 0.716 and 0.505). Additionally, vitreoretinal interface abnormality was associated with purine metabolism (OR = 5.820, 95% CI: 1.136-29.811) and DNA repair score (OR = 3.790, 95% CI: 1.096-13.109), while DRIL (OR = 0.214, 95% CI: 0.046-0.990) was associated with DNA repair score.</p><p><strong>Conclusions: </strong>PDME is characterized by elevated BMI, serum triglyceride, low SRF incidence, but a higher rate of DRIL and vitreoretinal interface abnormality. Purine metabolism and DNA repair pathways were associated with treatment response and correlated with OCT structural changes. Metabolomic signatures, particularly the purine score, emerged as promising candidate markers associated with pDME in this exploratory cohort, warranting further validation in independent studies. A novel mechanism of pDME, the purine metabolism-DNA repair axis, was proposed and needs further verification.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"11632-11642"},"PeriodicalIF":6.1,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13730987/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149011704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alexander Hamilton, Louise Thisted, Maria Ougaard, Max Hahn, Kasper Andersen, Johanna Perens, Robert Augustin, Besnik Bajrami, Wolfgang Rist, Michael Christensen, Henrik H Hansen, Thomas Klein
{"title":"Nephroprotective Effects of the Dual GCGR/GLP-1R Agonist Survodutide in Hypertension-Accelerated Diabetic Kidney Disease.","authors":"Alexander Hamilton, Louise Thisted, Maria Ougaard, Max Hahn, Kasper Andersen, Johanna Perens, Robert Augustin, Besnik Bajrami, Wolfgang Rist, Michael Christensen, Henrik H Hansen, Thomas Klein","doi":"10.1111/dom.71387","DOIUrl":"10.1111/dom.71387","url":null,"abstract":"<p><strong>Aims: </strong>Survodutide is a novel long-acting dual glucagon (GCGR)/glucagon-like peptide-1 (GLP-1R) receptor agonist currently in phase-3 clinical development for the treatment of people living with obesity and metabolic dysfunction-associated steatohepatitis. Emerging evidence suggests impaired renal GCGR function in chronic kidney disease (CKD), including diabetic kidney disease (DKD). This study aimed to characterize the effects of survodutide in a translational mouse model of advanced DKD, induced by adeno-associated virus-mediated renin overexpression (ReninAAV) in uninephrectomized (UNx) diabetic db/db mice.</p><p><strong>Materials and methods: </strong>Female obese and diabetic db/db C57BKS mice received a single intravenous dose of ReninAAV 1 week prior to UNx. Three weeks post-UNx, db/db UNx-ReninAAV mice were administered (s.c., q.d.) vehicle or survodutide (7.5 nmol/kg) for 10 weeks. Endpoints included blood/urine biochemistry, histological markers of glomerulosclerosis, tubular injury and inflammation, as well as quantitative 3D whole-pancreas and whole-kidney imaging.</p><p><strong>Results: </strong>Compared to vehicle controls, survodutide reduced body weight, hyperglycemia, and HbA1c levels concurrent with improved hyperinsulinemia and β-cell islet volume distribution. Notably, survodutide promoted substantial benefits on advanced albuminuria, severe glomerulosclerosis, kidney hypertrophy and inflammation. 3D whole-kidney imaging revealed that survodutide significantly reduced kidney and glomerular hypertrophy while increasing glomerular density and improving glomerular sphericity. Survodutide reduced liver weight and plasma amino acid levels, including alanine, confirming hepatic glucagon receptor activation.</p><p><strong>Conclusions: </strong>Survodutide markedly improved metabolic and renal outcomes in the db/db UNx-ReninAAV mouse model of advanced DKD, supporting further investigation into therapeutic options of survodutide in chronic kidney diseases.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"11915-11926"},"PeriodicalIF":6.1,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149101435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hanh M Vo, Timothy J Brodribb, Frances C Sussmilch
{"title":"Mutant Characterisation Reveals Two Candidate Sensors for the Rapid High Vapour Pressure Deficit (VPD) Response Pathway.","authors":"Hanh M Vo, Timothy J Brodribb, Frances C Sussmilch","doi":"10.1111/pce.70857","DOIUrl":"10.1111/pce.70857","url":null,"abstract":"","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"9732-9734"},"PeriodicalIF":6.9,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725248/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148862795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Wild Soybean C3HC4-Type RING Zinc-Finger Protein ZFP4 Enhances Resistance to Soybean Mosaic Virus.","authors":"Yixiang Pu, Yingying Song, Rufei Yang, Changyun Yang, Zhongyi Yang, Shupeng Dong, Wei Zhao, Jiao Wang, Zhiping Huang, Wei Li, Yingdong Bi, Yongcai Lai, Hengyou Zhang, Hui Wang, Deyue Yu, Qian Wu, Hao Cheng","doi":"10.1111/pce.70880","DOIUrl":"10.1111/pce.70880","url":null,"abstract":"<p><p>Soybean [Glycine max (L.) Merr.] is a globally important source of protein and edible oil, but is severely threatened by soybean mosaic virus (SMV). Wild soybean [Glycine soja Sieb. & Zucc.], the wild ancestor of cultivated soybean, exhibits high genetic diversity and strong resistance to pathogens. In this study, we identified a novel SMV resistance locus R<sub>SC7</sub>-4 and its candidate gene ZFP4 from wild soybean, encoding a C3HC4-type RING zinc-finger protein. The knockout mutants of ZFP4 showed enhanced susceptibility to SMV strains SC7 and SC3, while its overexpressing lines conferred resistance without yield penalty; ZFP4 mediates resistance by inhibiting GSTT1 to increase glutathione and reduce excessive reactive oxygen species accumulation. Domestication analysis revealed reduced genetic diversity of ZFP4 in cultivated soybean, with the resistant ZFP4<sup>Hap1</sup> underutilized in breeding. In summary, this study provides not only excellent genetic resources for SMV-resistant soybean breeding but also new insights into the regulatory mechanisms of soybean resistance to SMV.</p>","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"10149-10162"},"PeriodicalIF":6.9,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148962784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effectiveness, Safety and Pharmacokinetics of BGM0504, a Dual GLP-1/GIP Receptor Agonist, in Chinese Adults With Overweight or Obesity Without Diabetes: A Phase 2 Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial.","authors":"Linong Ji, Guoping Yang, Yangqing Huang, Haifeng Ding, Daosheng Xie, Xiaohui Jiang, Xuemei Yuan, Zhao Cao, Zou Chan, Haibin Zhang, Jiandong Yuan","doi":"10.1111/dom.71193","DOIUrl":"10.1111/dom.71193","url":null,"abstract":"<p><strong>Aims: </strong>To evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and efficacy of the dual GLP-1R/GIPR agonist BGM0504 in Chinese adults with overweight or obesity without diabetes.</p><p><strong>Materials and methods: </strong>In this randomized, double-blind, placebo-controlled, parallel-group phase 2 trial, 120 participants were assigned (1:1:1:1) to receive once-weekly subcutaneous injections of BGM0504 5 mg, 10 mg, 15 mg, or placebo for 24 weeks. The primary endpoint was percentage change in body weight from baseline to week 24. Key secondary endpoints included absolute body weight change, waist circumference, and the proportions of participants achieving prespecified weight-loss targets. Safety was assessed using adverse events, laboratory tests, and vital signs. The trial was registered with the Chinese National Medical Products Administration (CTR20233198) and ClinicalTrials.gov (NCT06973681).</p><p><strong>Results: </strong>Mean percentage changes in body weight from baseline to week 24 were -10.68%, -16.07%, -18.33%, and 0.13% with BGM0504 5 mg, 10 mg, 15 mg, and placebo, respectively; all BGM0504 doses were significantly superior to placebo (all p < 0.0001). Mean reductions in waist circumference were -8.88 cm, -12.71 cm, -14.38 cm, and -1.03 cm, respectively (all p < 0.001 vs. placebo). The proportions of participants achieving clinically meaningful weight loss increased in a dose-dependent manner across BGM0504 groups versus placebo (all p < 0.001). PK analyses showed an approximately linear dose-exposure relationship across the evaluated dose range. TEAEs occurred in 96.7%, 93.5%, 100.0%, and 86.7% of participants in the BGM0504 5 mg, 10 mg, 15 mg, and placebo groups, respectively, and drug-related adverse events occurred in 53.3%, 80.6%, 93.1%, and 40.0%. The most common selected TEAEs were gastrointestinal, including nausea, diarrhoea, and vomiting. One serious adverse event occurred in the 10 mg group and no TEAEs led to trial withdrawal.</p><p><strong>Conclusions: </strong>Once-weekly BGM0504 was associated with substantial dose-dependent weight loss and acceptable tolerability in Chinese adults with overweight or obesity without diabetes, supporting further clinical development.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"11463-11474"},"PeriodicalIF":6.1,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148987320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hydraulic Strategies of Cool-Temperate Trees and Lianas Against Freeze-Thaw Embolism: Is Cold Winter More Severe on Lianas?","authors":"Ryuji Ichihashi, Haruhiko Taneda, Yasuhiro Utsumi","doi":"10.1111/pce.70889","DOIUrl":"10.1111/pce.70889","url":null,"abstract":"<p><p>Lianas are abundant and influential in tropical forests but decline sharply in cooler regions. This pattern has been attributed to their reliance on a small number of large vessels, which are vulnerable to freeze-thaw embolism. However, the hydraulic functioning of lianas in cooler regions remains poorly understood. We examined the hydraulic properties of nine tree and four liana species in a cool-temperate forest. Compared with tree branches of similar diameter and age, liana branches had substantially wider vessels and, on average, 10 times greater specific conductivity (K<sub>s</sub>), supporting approximately six times more leaf area. While they experienced a nearly complete loss of K<sub>s</sub> during winter, conductivity was fully restored before or during leaf expansion. This recovery was achieved either by refilling embolised vessels using positive xylem pressure or by reconstructing the hydraulic pathway with newly formed vessels, similar to mechanisms observed in trees. Seasonal sap-flow patterns during the growing season fell within the range observed for trees. Thus, cool-temperate lianas maintained hydraulic function at least as effectively as trees. Our results do not support a simple freeze-vulnerability hypothesis but instead suggest that the ecological success of cool-temperate lianas depends strongly on mechanisms that restore stem hydraulic function after winter.</p>","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"10269-10279"},"PeriodicalIF":6.9,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725252/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148987432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HepatologyPub Date : 2026-12-01Epub Date: 2026-05-28DOI: 10.1097/HEP.0000000000001798
Julius Chapiro
{"title":"Metabolic reprogramming of the tumor microenvironment during transarterial therapy: Where no catheter has gone before.","authors":"Julius Chapiro","doi":"10.1097/HEP.0000000000001798","DOIUrl":"10.1097/HEP.0000000000001798","url":null,"abstract":"","PeriodicalId":177,"journal":{"name":"Hepatology","volume":" ","pages":"1617-1619"},"PeriodicalIF":18.0,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148040480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Leticia W Ribeiro, Jenny Doust, Gregore I Mielke, Gita D Mishra
{"title":"Obesity and Midlife Performance: A Cross-Sectional and Longitudinal Analysis of Women in the Menarche-To-PreMenopause Study.","authors":"Leticia W Ribeiro, Jenny Doust, Gregore I Mielke, Gita D Mishra","doi":"10.1111/dom.71349","DOIUrl":"10.1111/dom.71349","url":null,"abstract":"<p><strong>Background: </strong>The interplay between obesity and physical performance in women is poorly understood, especially before the fifties.</p><p><strong>Objective: </strong>To assess associations between weight gain from early to mid-adulthood and midlife performance-based physical function.</p><p><strong>Methods: </strong>499 women from the Menarche-to-PreMenopause Study completed handgrip strength, chair rise, and standing balance tests at age 41-48. The lowest tertile was defined as the 'worse performance' group. Weight and height were self-reported across eight surveys, from ages 18-23 to 40-45, and used to determine body mass index (BMI) trajectories using group-based trajectory modelling, as well as to estimate annual weight gain percentages. Other obesity indicators included BMI, waist circumference (WC), and waist-to-hip ratio (WHR) measured cross-sectionally at age 41-48.</p><p><strong>Results: </strong>Two BMI trajectories were identified: Normal-Increasing (75%) and High-Increasing (25%). The High-Increasing BMI trajectory showed approximately 40% higher prevalence of worse chair-rise and standing-balance performances compared to the Normal-Increasing group (95% CI: 9%-84%, p = 0.01; and 10%-84%, p = 0.008). Higher annual weight gain percentage showed a prevalence ratio (PR) 1.21 times higher for worse standing balance performance (95% CI: 1.06-1.38, p = 0.004). Midlife obesity (BMI ≥ 30 kg/m<sup>2</sup>), high-risk WC (≥ 80 cm) and WHR (≥ 0.8) were also associated with a higher prevalence of worse performance on the chair rise and standing balance tests, with PRs from 1.41 to 1.55. No consistent evidence was found for handgrip strength.</p><p><strong>Conclusions: </strong>Weight gain from early to mid-adulthood was associated with worse performance on the chair rise and standing balance tests in midlife, highlighting the potential of early weight-control strategies to preserve midlife performance.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"11373-11383"},"PeriodicalIF":6.1,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13730985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148965788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Managing Type 1 Diabetes in Neurodiverse Children and Young People: A Qualitative Exploration of Complexity and Care Challenges.","authors":"Zoe Tattersall, Sze May Ng","doi":"10.1111/dom.71363","DOIUrl":"10.1111/dom.71363","url":null,"abstract":"<p><strong>Background: </strong>Neurodiversity is an umbrella term encompassing multiple diagnoses including attention-deficit/hyperactivity disorder (ADHD) and autistic spectrum conditions. Current research is limited but highlights the complexities faced by caregivers who often face unique challenges in managing Type 1 diabetes (T1D). Little is known within the literature of the experiences of children and young people (CYP) and their caregivers where both diagnoses co-exist and how these translate to their day-to-day T1D management. This study aims to understand the perceived burdens of neurodiversity for CYP and their caregivers in managing their T1D.</p><p><strong>Methods: </strong>A qualitative methodology of semi-structured in-depth interviewing was used to explore the barriers, challenges, perceptions and impact on quality-of-life managing diabetes with neurodiversity. A thematic analysis was used to analyse the data.</p><p><strong>Results: </strong>Fifteen CYP (age range 12-18 years) and 13 parents caregivers were interviewed. All CYP had a diagnosis of autism, ADHD or both. Common themes identified were related to caregivers needing to adapt routines to meet individual needs. Family support was central to diabetes management. Sleep disturbance related to fear of hypoglycaemia was common, but continuous glucose monitoring improved sleep quality and reduced anxiety. Diabetes technologies, were widely perceived to reduce burden, enhance confidence and support self-management, despite occasional sensory challenges. Caregivers expressed concerns about limited tailored resources. CYP were worried about transition to adult services. Both CYP and caregiver experiences at diagnosis were generally negative, particular issues being change in routine, fingerpricks and hospital settings. CYP did not view neurodiversity as a barrier to self-managing their own diabetes.</p><p><strong>Conclusion: </strong>Caregivers demonstrate resilience in managing and navigating challenges and CYP did not see their neurodiversity as a barrier to managing their T1D. Diabetes technologies were viewed as improving quality of life. Day-to-day coping strategies varied between CYP and caregivers. Effective T1D management in CYP with neurodiversity necessitates that healthcare providers are trained to understand and address the specific needs of neurodiversity. This includes adapting communication strategies and developing individualised care plans. Future research is needed to develop tailored interventions and support systems specifically for CYP with T1D and neurodiversity.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"11432-11439"},"PeriodicalIF":6.1,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148975168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}